Achieve Life Sciences (ACHV) Earnings Analysis

Achieve Life Sciences (ACHV) next reports earnings on 2026-08-06, consensus EPS -0.18 USD. Last quarter (2026-03-24) it missed with EPS -0.28 USD vs -0.27 USD est (-3.7%). It has beaten estimates in 0/3 recent quarters (0%). Trailing P/E -5.63.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ACHV next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate-0.18 USD
Revenue estimaten/a

ACHV earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-24-0.28 USD-0.27 USD-3.7%Miss
2025-11-06-0.28 USD-0.24 USD-16.7%Miss
2025-03-11-0.36 USD-0.3 USD-20%Miss

Beat rate: 0/3 (0%) over reported quarters with consensus data.

ACHV valuation and analyst view

Trailing P/E-5.63
Trailing EPS-0.97391 USD
Price / book31.55
Dividend yield0.00%
Market cap0.65B
Analyst consensusBuy (6 buy / 0 hold / 0 sell)
Avg price target20 USD

Related research pages

Frequently asked questions

When is Achieve Life Sciences (ACHV)'s next earnings date?

Achieve Life Sciences is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.18 USD.

Did ACHV beat earnings last quarter?

In its 2026-03-24 report, ACHV posted EPS of -0.28 USD versus a -0.27 USD estimate — a miss of 3.7%.

What is ACHV's earnings track record?

Over the last 3 reported quarters with consensus data, ACHV beat estimates 0 times (0%).

What is ACHV's current P/E ratio and EPS?

ACHV trades at a trailing P/E of -5.63 on trailing EPS of -0.9739052623160969 USD.

What do analysts rate ACHV?

Analyst consensus is "Buy" across 6 ratings (0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 20 USD.